Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.United States |
First Approval Date01 Jan 1982 |
100 Clinical Results associated with Lyne Laboratories, Inc.
0 Patents (Medical) associated with Lyne Laboratories, Inc.
100 Deals associated with Lyne Laboratories, Inc.
100 Translational Medicine associated with Lyne Laboratories, Inc.